Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 14, 2022; 28(18): 2008-2020
Published online May 14, 2022. doi: 10.3748/wjg.v28.i18.2008
Table 1 Baseline characteristics for participants with and without major gastrointestinal bleedings during follow-up
Baseline characteristics
GIB, n = 403
No GIB, n = 33105
Overall, n = 33508
Age at baseline, mean (SD)56.0 (12.1)46.8 (13.0)46.9 (13.0)
Sex
Male256 (63.5)15768 (47.6)16024 (47.8)
Female147 (36.5)17337 (52.4)17484 (52.2)
Yr of enrollment, Q1
198745 (11.2)5872 (17.7)5917 (17.7)
199251 (12.7)5371 (16.2)5422 (16.2)
1997126 (31.3)7857 (23.7)7983 (23.8)
2002108 (26.8)8155 (24.6)8263 (24.7)
200773 (18.1)5850 (17.7)5923 (17.7)
Region1
West163 (40.4)12570 (38.0)12733 (38.0)
East240 (59.6)20535 (62.0)20775 (62.0)
Marital status
Married, cohabiting, or registered partnership278 (69.0)24391 (73.7)24669 (73.6)
Single, separated, divorced, or widow125 (31.0)8623 (26.0)8748 (26.1)
Missing0 (0.0)91 (0.3)91 (0.3)
Occupation
Non-manual (office/studying)102 (25.3)15889 (48.0)15991 (47.7)
Manual (factory/construction/farming/forestry)62 (15.4)6692 (20.2)6754 (20.2)
Family/housewife/pensioner191 (47.4)8033 (24.3)8224 (24.5)
Unemployed37 (9.2)2006 (6.1)2043 (6.1)
Missing11 (2.7)485 (1.5)496 (1.5)
Education in tertiles2
Low128 (31.8)10029 (30.3)10157 (30.3)
Moderate113 (28.0)10735 (32.4)10848 (32.4)
High144 (35.7)11619 (35.1)11763 (35.1)
Missing18 (4.5)722 (2.2)740 (2.2)
Smoking
Never168 (41.7)17381 (52.5)17549 (52.4)
Ex-smoker121 (30.0)7028 (21.2)7149 (21.3)
Smoker105 (26.1)8273 (25.0)8378 (25.0)
Missing9 (2.2)423 (1.3)432 (1.3)
Alcohol consumption in grams per week
Non-drinker164 (40.7)12548 (37.9)12712 (37.9)
Mild (0.1 g to 36.9 g)65 (16.1)6835 (20.6)6900 (20.6)
Moderate (37 g to 86.9 g)54 (13.4)5914 (17.9)5968 (17.8)
Heavy (≥ 87g)101 (25.1)6879 (20.8)6980 (20.8)
Missing19 (4.7)929 (2.8)948 (2.8)
Coffee consumption per day, cups
0 38 (9.4)2858 (8.6)2896 (8.6)
1–5 267 (66.3)20294 (61.3)20561 (61.4)
6–10 86 (21.3)9008 (27.2)9094 (27.1)
> 10 4 (1.0)637 (1.9)641 (1.9)
Missing8 (2.0)308 (0.9)316 (0.9)
Physical activity
Minimal to mild335 (83.1)25306 (76.4)25641 (76.5)
Moderate to heavy52 (12.9)7095 (21.4)7147 (21.3)
Missing16 (4.0)704 (2.1)720 (2.1)
Body mass index in kg/m2, mean (SD)28.3 (5.2)26.6 (4.6)26.6 (4.6)
Missing10 (2.5)389 (1.2)399 (1.2)
Waist-hip ratio, mean (SD)0.93 (0.1)0.88 (0.1)0.88 (0.1)
Missing5 (1.2)404 (1.2)409 (1.2)
Systolic blood pressure in mm Hg, mean (SD)141.0 (22)136.0 (20)136.0 (20)
Missing2 (0.5)268 (0.8)270 (0.8)
Diastolic blood pressure in mm Hg, mean (SD)83.5 (12.7)81.0 (11.7)81.0 (11.7)
Missing2 (0.5)271 (0.8)273 (0.8)
Total cholesterol in mmol/L, mean (SD)5.69 (1.09)5.58 (1.12)5.58 (1.12)
Missing5 (1.2)347 (1.0)352 (1.1)
High density lipoprotein in mmol/L, mean (SD)1.39 (0.44)1.44 (0.38)1.44 (0.38)
Missing5 (1.2)347 (1.0)352 (1.1)
Gamma-glutamyl transferase in U/L, mean (SD)59.5 (141)31.2 (45.0)31.5 (47.4)
Missing5 (1.2)356 (1.1)361 (1.1)
Table 2 Medical history in participants with and without gastrointestinal bleeding
Comorbidities
GIB, n = 403
No GIB, n = 33105
Overall, n = 33508
Precursors of GIBs1
0355 (88.1)31621 (95.5)31976 (95.4)
145 (11.2)1399 (4.2)1444 (4.3)
23 (0.7)78.0 (0.2)81.0 (0.2)
30 (0)7.00 (0.0)7.00 (0.0)
Any cancer 63 (15.6)2421 (7.3)2484 (7.4)
Any psychiatric disorders 104 (25.8)4653 (14.1)4757 (14.2)
Stroke including SAH39 (9.7)1239 (3.7)1278 (3.8)
Venous thromboembolism 17 (4.2)728 (2.2)745 (2.2)
Ischemic heart disease 101 (25.1)3433 (10.4)3534 (10.5)
Valvular heart disease 23 (5.7)689 (2.1)712 (2.1)
Atrial fibrillation 55 (13.6)1512 (4.6)1567 (4.7)
Peripheral artery disease 23 (5.7)553 (1.7)576 (1.7)
Heart failure76 (18.9)1810 (5.5)1886 (5.6)
High blood pressure 128 (31.8)6572 (19.9)6700 (20.0)
Osteoarthritis 20 (5.0)2062 (6.2)2082 (6.2)
Inflammatory connective tissue diseases29 (7.2)1458 (4.4)1487 (4.4)
Diabetes252 (12.9)2390 (7.2)2442 (7.3)
COPD 24 (6.0)638 (1.9)662 (2.0)
Asthma 54 (13.4)3828 (11.6)3882 (11.6)
Liver disorder 29 (7.2)389 (1.2)418 (1.2)
Anemia6 (1.5)70 (0.2)76 (0.2)
Table 3 Multivariate analysis for the risk factors for major gastrointestinal bleeding
Variables
Univariate model, HR (95%CI)
Multivariate model, HR (95%CI)
Baseline age (10-yr increase)1.83 (1.69–1.99)1.62 (1.42–1.86)
Sex
Male11
Female0.51 (0.42–0.63)0.83 (0.59–1.17)
Yr of enrollment
198711
19921.23 (0.83-1.84)1.15 (0.74–1.79)
19972.10 (1.50–2.96)1.36 (0.91–2.04)
20021.72 (1.21–2.43)1.10 (0.72–1.68)
20071.66 (1.15–2.41)0.90 (0.57–1.43)
Region1
West Finland11
East Finland0.90 (0.74–1.10)0.96 (0.77–1.20)
Marital status
Married, cohabiting, or registered partnership11
Single, separated, divorced, or widow1.29 (1.04–1.59)1.09 (0.86–1.38)
Occupation
Non-manual (office/studying)11
Manual (factory/ construction/ farming/ forestry)1.45 (1.06–1.98)1.25 (0.88–1.78)
Family/ housewife/ pensioner3.90 (3.06–4.95)1.26 (0.90–1.75)
Unemployed2.92 (2.00–4.25)1.70 (1.11–2.59)
Education2
Low11
Moderate0.82 (0.64–1.06)0.81 (0.62–1.06)
High0.96 (0.76–1.22)1.05 (0.80–1.38)
Smoking
Never11
Ex-smoker1.80 (1.43–2.28)1.18 (0.90–1.53)
Smoker1.34 (1.05–1.71)1.30 (0.97–1.74)
Alcohol consumption in grams per week
Non-User11
Mild (0.1 g to 36.9 g)0.72 (0.54–0.96)0.88 (0.66–1.19)
Moderate (37 g to 86.9 g)0.69 (0.51–0.94)0.76 (0.54–1.06)
Heavy (≥ 87 g)1.13 (0.88–1.44)1.02 (0.76–1.37)
Coffee consumption per day, cups
0 11
1–5 1.00 (0.71–1.40)0.72 (0.50–1.02)
6–10 0.72 (0.49–1.06)0.67 (0.46–0.99)
> 10 0.48 (0.17–1.33)0.43 (0.23–0.81)
Physical activity
None to Mild11
Moderate to Heavy0.55 (0.41–0.73)0.85 (0.62–1.16)
Body mass index standardized1.38 (1.27–1.50)1.15 (1.01–1.32)
Waist hip ratio standardized1.70 (1.55–1.86)1.18 (0.98–1.43)
Systolic blood pressure standardized 1.30 (1.19–1.42)0.85 (0.76-0.96)
Diastolic blood pressure standardized 1.24 (1.13–1.37)-
Total cholesterol standardized1.10 (1.00–1.21)0.94 (0.84–1.05)
High density lipoprotein standardized0.86 (0.77–0.95)-
Gamma-glutamyl transferase standardized1.10 (1.08–1.12)1.05 (1.02-1.09)
Precursors of GIB3
011
≥ 19.44 (7.65–11.65)1.90 (1.37–2.63)
Any cancer2.66 (2.03–3.48)1.47 (1.10–1.97)
Any psychiatric disorders2.21 (1.77–2.77)1.32 (1.01–1.71)
Stroke including SAH2.98 (2.14–4.15)1.31 (0.90–1.90)
Venous thromboembolism2.04 (1.26–3.32)-
Ischemic heart disease3.14 (2.51–3.94)1.16 (0.87-1.55)
Valvular heart disease2.91 (1.91–4.44)1.40 (0.88-2.25)
Atrial fibrillation3.46 (2.60–4.60)1.05 (0.73–1.51)
Peripheral artery disease3.94 (2.59–6.00)1.39 (0.87–2.23)
Heart failure4.35 (3.39–5.58)1.46 (1.04–2.05)
High blood pressure1.92 (1.55–2.36)0.90 (0.69–1.17)
Osteoarthritis0.78 (0.50–1.23)0.39 (0.24–0.65)
Connective tissue diseases1.72 (1.18–2.51)-
Diabetes41.97 (1.47–2.64)0.76 (0.54–1.08)
Chronic obstructive pulmonary disease3.57 (2.36–5.39)1.26 (0.77–2.06)
Asthma1.19 (0.89–1.58)0.80 (0.58–1.11)
Liver disorder6.95 (4.76–10.15)3.20 (2.06–4.97)
Anemia7.16 (3.20–16.04)1.52 (0.48–4.83)